Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 63

1.

Interindividual and Regional Variability in Drug Transporter Abundance at the Human Blood-Brain Barrier Measured by Quantitative Targeted Proteomics.

Billington S, Salphati L, Hop CECA, Chu X, Evers R, Burdette D, Rowbottom C, Lai Y, Xiao G, Humphreys WG, Nguyen TB, Prasad B, Unadkat JD.

Clin Pharmacol Ther. 2019 Jan 23. doi: 10.1002/cpt.1373. [Epub ahead of print]

PMID:
30673124
2.

A Comparison of Vagal Nerve Stimulation and Responsive Neurostimulation for the Treatment of Medically Refractory Complex Partial Epilepsy.

Ellens NR, Elisevich K, Burdette DE, Patra SE.

Stereotact Funct Neurosurg. 2018;96(4):259-263. doi: 10.1159/000492232. Epub 2018 Aug 27.

PMID:
30149389
3.

The Smc5/6 Complex Restricts HBV when Localized to ND10 without Inducing an Innate Immune Response and Is Counteracted by the HBV X Protein Shortly after Infection.

Niu C, Livingston CM, Li L, Beran RK, Daffis S, Ramakrishnan D, Burdette D, Peiser L, Salas E, Ramos H, Yu M, Cheng G, Strubin M, Delaney WE IV, Fletcher SP.

PLoS One. 2017 Jan 17;12(1):e0169648. doi: 10.1371/journal.pone.0169648. eCollection 2017.

4.

Periodic Discharges: Insight From Magnetoencephalography.

Shvarts V, Zoltay G, Bowyer SM, Zillgitt A, Moran JE, Mason K, Tepley N, Burdette D.

J Clin Neurophysiol. 2017 May;34(3):196-206. doi: 10.1097/WNP.0000000000000356.

PMID:
27832046
5.

Influenza A virus targets a cGAS-independent STING pathway that controls enveloped RNA viruses.

Holm CK, Rahbek SH, Gad HH, Bak RO, Jakobsen MR, Jiang Z, Hansen AL, Jensen SK, Sun C, Thomsen MK, Laustsen A, Nielsen CG, Severinsen K, Xiong Y, Burdette DL, Hornung V, Lebbink RJ, Duch M, Fitzgerald KA, Bahrami S, Mikkelsen JG, Hartmann R, Paludan SR.

Nat Commun. 2016 Feb 19;7:10680. doi: 10.1038/ncomms10680.

6.

Spin Labeling of Potassium Channels.

Burdette D, Gross A.

Methods Enzymol. 2015;564:389-400. doi: 10.1016/bs.mie.2015.06.005. Epub 2015 Jul 22.

PMID:
26477258
7.

Intracranial electrographic analysis of preictal spiking and ictal onset in uni- and bitemporal epilepsy.

Wasade VS, Gaddam S, Burdette DE, Schultz L, Spanaki-Varelas M, Constantinou JE, Elisevich K.

Epileptic Disord. 2015 Jun;17(2):156-64.

8.

Identification of 2-aminothiazolobenzazepine metabolites in human, rat, dog, and monkey microsomes by ion-molecule reactions in linear quadrupole ion trap mass spectrometry.

Zhang M, Eismin R, Kenttämaa H, Xiong H, Wu Y, Burdette D, Urbanek R.

Drug Metab Dispos. 2015 Mar;43(3):358-66. doi: 10.1124/dmd.114.061978. Epub 2014 Dec 29.

PMID:
25547868
9.

Vibrio effector protein VopQ inhibits fusion of V-ATPase-containing membranes.

Sreelatha A, Bennett TL, Carpinone EM, O'Brien KM, Jordan KD, Burdette DL, Orth K, Starai VJ.

Proc Natl Acad Sci U S A. 2015 Jan 6;112(1):100-5. doi: 10.1073/pnas.1413764111. Epub 2014 Dec 1.

10.

Occurrences and fate of DDT principal isomers/metabolites, DDA, and o,p'-DDD enantiomers in fish, sediment and water at a DDT-impacted Superfund site.

Garrison AW, Cyterski M, Roberts KD, Burdette D, Williamson J, Avants JK.

Environ Pollut. 2014 Nov;194:224-234. doi: 10.1016/j.envpol.2014.07.025. Epub 2014 Aug 25.

PMID:
25150505
11.

Structures of KcsA in complex with symmetrical quaternary ammonium compounds reveal a hydrophobic binding site.

Lenaeus MJ, Burdette D, Wagner T, Focia PJ, Gross A.

Biochemistry. 2014 Aug 19;53(32):5365-73. doi: 10.1021/bi500525s. Epub 2014 Aug 8.

12.

The innate immune DNA sensor cGAS produces a noncanonical cyclic dinucleotide that activates human STING.

Diner EJ, Burdette DL, Wilson SC, Monroe KM, Kellenberger CA, Hyodo M, Hayakawa Y, Hammond MC, Vance RE.

Cell Rep. 2013 May 30;3(5):1355-61. doi: 10.1016/j.celrep.2013.05.009. Epub 2013 May 23.

13.

STING-dependent recognition of cyclic di-AMP mediates type I interferon responses during Chlamydia trachomatis infection.

Barker JR, Koestler BJ, Carpenter VK, Burdette DL, Waters CM, Vance RE, Valdivia RH.

MBio. 2013 Apr 30;4(3):e00018-13. doi: 10.1128/mBio.00018-13.

14.

Mouse, but not human STING, binds and signals in response to the vascular disrupting agent 5,6-dimethylxanthenone-4-acetic acid.

Conlon J, Burdette DL, Sharma S, Bhat N, Thompson M, Jiang Z, Rathinam VA, Monks B, Jin T, Xiao TS, Vogel SN, Vance RE, Fitzgerald KA.

J Immunol. 2013 May 15;190(10):5216-25. doi: 10.4049/jimmunol.1300097. Epub 2013 Apr 12.

15.

STING and the innate immune response to nucleic acids in the cytosol.

Burdette DL, Vance RE.

Nat Immunol. 2013 Jan;14(1):19-26. doi: 10.1038/ni.2491. Review.

PMID:
23238760
16.

Retigabine as adjunctive therapy in adults with partial-onset seizures: integrated analysis of three pivotal controlled trials.

Porter RJ, Burdette DE, Gil-Nagel A, Hall ST, White R, Shaikh S, DeRossett SE.

Epilepsy Res. 2012 Aug;101(1-2):103-12. doi: 10.1016/j.eplepsyres.2012.03.010. Epub 2012 Apr 16.

PMID:
22512894
17.

Hepatitis C virus activates interleukin-1β via caspase-1-inflammasome complex.

Burdette D, Haskett A, Presser L, McRae S, Iqbal J, Waris G.

J Gen Virol. 2012 Feb;93(Pt 2):235-46. doi: 10.1099/vir.0.034033-0. Epub 2011 Oct 12.

18.

STING is a direct innate immune sensor of cyclic di-GMP.

Burdette DL, Monroe KM, Sotelo-Troha K, Iwig JS, Eckert B, Hyodo M, Hayakawa Y, Vance RE.

Nature. 2011 Sep 25;478(7370):515-8. doi: 10.1038/nature10429.

19.

Elucidation of a novel bioactivation pathway of a 3,4-unsubstituted isoxazole in human liver microsomes: formation of a glutathione adduct of a cyanoacrolein derivative after isoxazole ring opening.

Yu J, Folmer JJ, Hoesch V, Doherty J, Campbell JB, Burdette D.

Drug Metab Dispos. 2011 Feb;39(2):302-11. doi: 10.1124/dmd.110.036285. Epub 2010 Nov 2.

PMID:
21045198
20.

In vitro metabolism studies of nomifensine monooxygenation pathways: metabolite identification, reaction phenotyping, and bioactivation mechanism.

Yu J, Brown DG, Burdette D.

Drug Metab Dispos. 2010 Oct;38(10):1767-78. doi: 10.1124/dmd.110.033910. Epub 2010 Jul 1.

PMID:
20595377
21.

PF-03475952: a potent and neutralizing fully human anti-CD44 antibody for therapeutic applications in inflammatory diseases.

Runnels HA, Weber GL, Min J, Kudlacz EM, Zobel JF, Donovan CB, Thiede MA, Zhang J, Alpert RB, Salafia MA, Milici AJ, Burdette D, Bell RR, Beebe JS, Xu X.

Adv Ther. 2010 Mar;27(3):168-80. doi: 10.1007/s12325-010-0010-0. Epub 2010 Apr 26.

PMID:
20429046
22.

Timing performance of the silicon PET insert probe.

Studen A, Burdette D, Chesi E, Cindro V, Clinthorne NH, Cochran E, Grosicar B, Kagan H, Lacasta C, Linhart V, Mikuz M, Stankova V, Weilhammer P, Zontar D.

Radiat Prot Dosimetry. 2010 Apr-May;139(1-3):199-203. doi: 10.1093/rpd/ncq076. Epub 2010 Mar 9.

23.

Rac GTPase is a hub for protein kinase A and Epac signaling in endothelial barrier protection by cAMP.

Birukova AA, Burdette D, Moldobaeva N, Xing J, Fu P, Birukov KG.

Microvasc Res. 2010 Mar;79(2):128-38. doi: 10.1016/j.mvr.2009.11.007. Epub 2009 Dec 3.

24.

Activation of transcription factor Nrf2 by hepatitis C virus induces the cell-survival pathway.

Burdette D, Olivarez M, Waris G.

J Gen Virol. 2010 Mar;91(Pt 3):681-90. doi: 10.1099/vir.0.014340-0. Epub 2009 Nov 4.

PMID:
19889935
25.
26.

Vibrio VopQ induces PI3-kinase-independent autophagy and antagonizes phagocytosis.

Burdette DL, Seemann J, Orth K.

Mol Microbiol. 2009 Aug;73(4):639-49. doi: 10.1111/j.1365-2958.2009.06798.x. Epub 2009 Jul 14.

27.

Not without cause: Vibrio parahaemolyticus induces acute autophagy and cell death.

Burdette DL, Yarbrough ML, Orth K.

Autophagy. 2009 Jan;5(1):100-2. Epub 2009 Jan 25.

28.

Periictal diffusion abnormalities of the thalamus in partial status epilepticus.

Katramados AM, Burdette D, Patel SC, Schultz LR, Gaddam S, Mitsias PD.

Epilepsia. 2009 Feb;50(2):265-75. doi: 10.1111/j.1528-1167.2008.01736.x.

29.

Vibrio parahaemolyticus orchestrates a multifaceted host cell infection by induction of autophagy, cell rounding, and then cell lysis.

Burdette DL, Yarbrough ML, Orvedahl A, Gilpin CJ, Orth K.

Proc Natl Acad Sci U S A. 2008 Aug 26;105(34):12497-502. doi: 10.1073/pnas.0802773105. Epub 2008 Aug 19.

30.

Development of an in vitro drug-drug interaction assay to simultaneously monitor five cytochrome P450 isoforms and performance assessment using drug library compounds.

Zientek M, Miller H, Smith D, Dunklee MB, Heinle L, Thurston A, Lee C, Hyland R, Fahmi O, Burdette D.

J Pharmacol Toxicol Methods. 2008 Nov-Dec;58(3):206-14. doi: 10.1016/j.vascn.2008.05.131. Epub 2008 Jun 25.

PMID:
18634893
31.

Learning clinical neurophysiology: gaming is better than lectures.

Schuh L, Burdette DE, Schultz L, Silver B.

J Clin Neurophysiol. 2008 Jun;25(3):167-9. doi: 10.1097/WNP.0b013e31817759b3.

PMID:
18469726
32.

Structural requirements for Yersinia YopJ inhibition of MAP kinase pathways.

Hao YH, Wang Y, Burdette D, Mukherjee S, Keitany G, Goldsmith E, Orth K.

PLoS One. 2008 Jan 2;3(1):e1375. doi: 10.1371/journal.pone.0001375.

33.

A prototype of very high resolution small animal PET scanner using silicon pad detectors.

Park SJ, Leslie Rogers W, Huh S, Kagan H, Honscheid K, Burdette D, Chesi E, Lacasta C, Llosa G, Mikuz M, Studen A, Weilhammer P, Clinthorne NH.

Nucl Instrum Methods Phys Res A. 2007 Jan 21;570(3):543-555.

34.

Arp2/3-independent assembly of actin by Vibrio type III effector VopL.

Liverman AD, Cheng HC, Trosky JE, Leung DW, Yarbrough ML, Burdette DL, Rosen MK, Orth K.

Proc Natl Acad Sci U S A. 2007 Oct 23;104(43):17117-22. Epub 2007 Oct 17.

35.

Performance evaluation of a very high resolution small animal PET imager using silicon scatter detectors.

Park SJ, Rogers WL, Huh S, Kagan H, Honscheid K, Burdette D, Chesi E, Lacasta C, Llosa G, Mikuz M, Studen A, Weilhammer P, Clinthorne NH.

Phys Med Biol. 2007 May 21;52(10):2807-26. Epub 2007 Apr 30.

36.

Two prospective educational interventions in a neurology residency: effect on RITE performance.

Schuh L, Burdette DE, Schultz L, Silver B.

Neurologist. 2007 Mar;13(2):79-82.

PMID:
17351527
37.

A novel method for assessing inhibition of ibuprofen chiral inversion and its application in drug discovery.

Reddy A, Hashim M, Wang Z, Penn L, Stankovic CJ, Burdette D, Surendran N, Cai H.

Int J Pharm. 2007 Apr 20;335(1-2):63-69. doi: 10.1016/j.ijpharm.2006.11.006. Epub 2006 Dec 14.

PMID:
17174047
38.

Polar head groups are important for barrier-protective effects of oxidized phospholipids on pulmonary endothelium.

Birukova AA, Fu P, Chatchavalvanich S, Burdette D, Oskolkova O, Bochkov VN, Birukov KG.

Am J Physiol Lung Cell Mol Physiol. 2007 Apr;292(4):L924-35. Epub 2006 Dec 8.

39.

The RACK1 homologue from Trypanosoma brucei is required for the onset and progression of cytokinesis.

Rothberg KG, Burdette DL, Pfannstiel J, Jetton N, Singh R, Ruben L.

J Biol Chem. 2006 Apr 7;281(14):9781-90. Epub 2006 Feb 9.

40.

Effects of kindling and irradiation on neuronal density in the rat dentate gyrus.

Jenrow KA, Ratkewicz AE, Lemke NW, Kadiyala M, Zalinski DN, Burdette DE, Elisevich KV.

Neurosci Lett. 2004 Nov 16;371(1):45-50.

PMID:
15500964
41.

Inhibition of MAPK signaling pathways by VopA from Vibrio parahaemolyticus.

Trosky JE, Mukherjee S, Burdette DL, Roberts M, McCarter L, Siegel RM, Orth K.

J Biol Chem. 2004 Dec 10;279(50):51953-7. Epub 2004 Sep 30.

42.

Initiation of an effective neurology resident ethics curriculum.

Schuh LA, Burdette DE.

Neurology. 2004 May 25;62(10):1897-8.

PMID:
15159507
43.

Homogeneous techniques for monitoring receptor-ligand interactions.

Marks JS, Burdette DS, Giegel DA.

Methods Mol Biol. 2002;190:51-63. No abstract available.

PMID:
12029826
44.

Physiological function of alcohol dehydrogenases and long-chain (C(30)) fatty acids in alcohol tolerance of Thermoanaerobacter ethanolicus.

Burdette DS, Jung SH, Shen GJ, Hollingsworth RI, Zeikus JG.

Appl Environ Microbiol. 2002 Apr;68(4):1914-8.

45.

Effect of thermal and chemical denaturants on Thermoanaerobacter ethanolicus secondary-alcohol dehydrogenase stability and activity.

Burdette DS, Tchernajencko V V, Zeikus JG.

Enzyme Microb Technol. 2000 Jul 1;27(1-2):11-18.

PMID:
10862896
46.

Serial magnetoencephalographic observations of a normally developing infant during sleep?

Bowyer SM, Burdette DE, Moran JE, Tepley N.

Dev Med Child Neurol. 2000 Feb;42(2):143-4. No abstract available.

47.

Muscarinic receptor loss and preservation of presynaptic cholinergic terminals in hippocampal sclerosis.

Pennell PB, Burdette DE, Ross DA, Henry TR, Albin RL, Sackellares JC, Frey KA.

Epilepsia. 1999 Jan;40(1):38-46.

48.

Flumazenil-responsive stupor.

Burdette DE.

Cephalalgia. 1998 Jan;18(1):5-6. No abstract available.

PMID:
9601618
49.

Biophysical and mutagenic analysis of Thermoanaerobacter ethanolicus secondary-alcohol dehydrogenase activity and specificity.

Burdette DS, Secundo F, Phillips RS, Dong J, Scott RA, Zeikus JG.

Biochem J. 1997 Sep 15;326 ( Pt 3):717-24.

Supplemental Content

Loading ...
Support Center